
Satellite Symposia
SATELLITE SYMPOSIA

nAMD Treatment Fundamentals: Keys to a Proactive and Individualized Anti-VEGF Treatment Approach for nAMD Patients
9 September, 14:00 CEST
Chairperson(s): A. Loewenstein ISRAEL & N. Eter GERMANY
nAMD Treatment Fundamentals: Keys to a Proactive and Individualized Anti-VEGF Treatment Approach for nAMD Patients

Beyond VEGF: Targeting the Ang-Tie Pathway for the Management of Retinal Diseases
9 September, 18:45 CEST
Chairperson(s): P. Schlottmann ARGENTINA
Beyond VEGF: Targeting the Ang-Tie Pathway for the Management of Retinal Diseases

The Big Picture in Clinical Practice
10 September, 11:00 CEST
Chairperson(s): A. Loewenstein ISRAEL
The Big Picture in Clinical Practice

Clinical Perspectives on nAMD Management: Making Informed Decisions Along the Patient Journey
10 September, 11:00 CEST
Chairperson(s): A. Koh SINGAPORE
Clinical Perspectives on nAMD Management: Making Informed Decisions Along the Patient Journey

Exploring New Retina Technologies and Beyond
10 September, 11:00 CEST
Chairperson(s): C. Mateo SPAIN
Exploring New Retina Technologies and Beyond

Restoring Vision in Advanced AMD: A Roundtable Discussion on Treatment Options
10 September, 11:00 CEST
Chairperson(s): J. Talamo USA
Restoring Vision in Advanced AMD: A Roundtable Discussion on Treatment Options

A Pathway to Enhanced Care for Inherited Retinal Dystrophy Patients
10 September, 14:00 CEST
Chairperson(s): B.P. Leroy BELGIUM
A Pathway to Enhanced Care for Inherited Retinal Dystrophy Patients

The Ophthalmology Clinic of 2030: What is on the Horizon?
10 September, 14:00 CEST
Chairperson(s): M. de Smet SWITZERLAND
The Ophthalmology Clinic of 2030: What is on the Horizon?

AMD and DME Treatment Innovations: Home Monitoring, Artificial Intelligence Diagnostics and Extended Duration Anti-VEGF Therapeutics
10 September, 14:00 CEST
Chairperson(s): A. Loewenstein ISRAEL
AMD and DME Treatment Innovations: Home Monitoring, Artificial Intelligence Diagnostics and Extended Duration Anti-VEGF Therapeutics

DME Management: Challenges and Opportunities
10 September, 18:00 CEST
Chairperson(s): T. Wong SINGAPORE
DME Management: Challenges and Opportunities

Geographic Atrophy: What Have we Learnt and What is Still to be Discovered?
10 September, 18:00 CEST
Chairperson(s): F.G. Holz GERMANY
Geographic Atrophy: What Have we Learnt and What is Still to be Discovered?

Optimising nAMD Management Through Longer-acting Therapies
10 September, 18:00 CEST
Chairperson(s): A. Laidlaw UK
Optimising nAMD Management Through Longer-acting Therapies

Looking into the Future: nAMD Detection and Progression
10 September, 18:00 CEST
Chairperson(s): A. Loewenstein ISRAEL
Looking into the Future: nAMD Detection and Progression

Controversies in Laser Treatments in 2021
10 September, 18:00 CEST
Chairperson(s): P. Stanga UK
Controversies in Laser Treatments in 2021

Digital Innovations: Jumping from Concepts to the Clinic
11 September, 11:00 CEST
Chairperson(s): N. Bressler USA
Digital Innovations: Jumping from Concepts to the Clinic

Maximizing Treatment Benefits for our Patients with Retinal Vascular Diseases
11 September, 11:00 CEST
Chairperson(s): J. Kitchens USA
Maximizing Treatment Benefits for our Patients with Retinal Vascular Diseases

Evolution in Surgical Techniques - The Modern VR Procedure
11 September, 11:00 CEST
Chairperson(s): R. Tadayoni FRANCE
Evolution in Surgical Techniques - The Modern VR Procedure

Best-informed Decision Making – Latest Innovations in Retinal Imaging and Surgical Visualization
11 September, 11:00 CEST
Chairperson(s): J.F Korobelnik FRANCE
Best-informed Decision Making – Latest Innovations in Retinal Imaging and Surgical Visualization

Managing Patients with Diabetic Macular Edema Through the Pandemic and Beyond: Discussing Ongoing Strategies
11 September, 14:00 CEST
Chairperson(s): R. Tadayoni FRANCE
Managing Patients with Diabetic Macular Edema Through the Pandemic and Beyond: Discussing Ongoing Strategies

Flexibility and Long-term Predictability: Unlocking the Potential of Q16 Dosing for your Patients
11 September, 14:00 CEST
Chairperson(s): D. Wong CANADA
Flexibility and Long-term Predictability: Unlocking the Potential of Q16 Dosing for your Patients

Amgen: Spotlight on Real-world Considerations for Biosimilars in Ophthalmology
11 September, 14:00 CEST
Chairperson(s): J. Franklin USA
Amgen: Spotlight on Real-world Considerations for Biosimilars in Ophthalmology

AMD Fluid Resolution: Optimizing Real-world Outcomes in nAMD Treatment
11 September, 18:15 CEST
Chairperson(s): F.G. Holz GERMANY